Search
CRISPR Therapeutics AG
CRSPAdd to Watchlist
58.380USD
+1.820+3.22%
Market hours 09/21, 11:55（ET）
5.64BMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+3.22%
5 Days
+12.88%
1 Month
+0.45%
6 Months
+26.25%
Year to Date
+11.33%
1 Year
-6.32%
Key Figures
57.490Open
59.020High
58.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
56.560Prev. Close
56.920Low
3.43MTurnover
LossP/E Static
3.23P/B
0.00%Div Yield TTM
-23.24%ROA
78.48052wk High
0.07Volume Ratio
-366.25MNet Profit
96.66MShares
-6.1650EPS TTM
1.74Beta
-31.21%ROE
44.12052wk Low
3.71%Amplitude
100.00%Gross Margin
5.64BMarket Cap
4.06Reward/Risk
3.76%Risk Rate
More news coming soon, stay tuned...
CRISPR Therapeutics AG's Score
0.09vs previous score
Forecast7.45
Financial Health6.85
Technical4.94
Valuation Dimensions8.42
Institutional Confidence7.00
Risk Assessment5.86
Media Coverage
Coverage Level
Very Low
Very High
Positive+
Analyst Rating
CRISPR Therapeutics AG Technical Analysis
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.94/-1.20
Revenue / Forecast
10.18M/6.79M
CRISPR Therapeutics AG Profile
SectorBiotechnology & Medical Research
Ticker SymbolCRSP
Number of employees393
CountrySwitzerland
Ownership
| Shareholders | Proportion |
|---|---|
| ARK Investment Management LLC | 11.73% |
| BlackRock Institutional Trust Company, N.A. | 6.92% |
| Orbis Investment Management Ltd. | 6.17% |
| State Street Investment Management (US) | 3.89% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 40.10% |
| Investment Advisor/Hedge Fund | 23.67% |
| Venture Capital | 3.37% |
| Corporation | 3.34% |
Related Instruments
+0.70%
+0.63%
+0.96%
+0.27%
+1.63%
+0.79%
+1.88%
+0.57%
-0.16%
-7.96%
+0.53%
-0.02%
+1.71%
+1.09%
+0.34%
+1.05%
+9.65%
+0.58%
-0.11%
+0.01%Popular Instruments
51930.400
+196.400 (+0.38%)
30315.300
+650.600 (+2.19%)
7737.300
+78.200 (+1.02%)
14566.000
+146.000 (+1.01%)
66403.000
+1324.000 (+2.03%)
6319.100
+88.300 (+1.42%)
92.246
-3.755 (-3.91%)
338.125
+1.995 (+0.59%)
224.960
+2.690 (+1.21%)
4348.380
-28.950 (-0.66%)
FAQs
What is the current price of CRISPR Therapeutics AG (CRSP)?
The current price of CRISPR Therapeutics AG (CRSP) is 56.56.
What is the symbol of CRISPR Therapeutics AG?
The ticker symbol of CRISPR Therapeutics AG is CRSP.
What is the 52-week high of CRISPR Therapeutics AG?
The 52-week high of CRISPR Therapeutics AG is 78.48.
What is the 52-week low of CRISPR Therapeutics AG?
The 52-week low of CRISPR Therapeutics AG is 44.12.
What is the market capitalization of CRISPR Therapeutics AG?
The market capitalization of CRISPR Therapeutics AG is 5.46B.
Is CRISPR Therapeutics AG (CRSP) currently rated as Buy, Hold, or Sell?
According to analysts, CRISPR Therapeutics AG (CRSP) has an overall rating of Buy, with a price target of 85.76.
What is the Earnings Per Share (EPS TTM) of CRISPR Therapeutics AG (CRSP)?
The Earnings Per Share (EPS TTM) of CRISPR Therapeutics AG (CRSP) is -6.16.